Income Statement Gerresheimer AG
Equities
GXI
DE000A0LD6E6
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
100.40 EUR | -2.52% | -2.43% | +6.41% |
Sep. 11 | GERRESHEIMER AG : Berenberg remains its Buy rating | ZD |
Sep. 11 | GERRESHEIMER AG : Jefferies gives a Buy rating | ZD |
Fiscal Period: November | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.39B | 1.42B | 1.5B | 1.82B | 1.99B | |||||
Total Revenues | 1.39B | 1.42B | 1.5B | 1.82B | 1.99B | |||||
Cost of Goods Sold, Total | 1B | 980M | 1.06B | 1.27B | 1.39B | |||||
Gross Profit | 388M | 439M | 442M | 547M | 597M | |||||
Selling General & Admin Expenses, Total | 273M | 275M | 287M | 351M | 373M | |||||
R&D Expenses | - | - | 10M | 21.62M | 16.13M | |||||
Other Operating Expenses | -223K | 10.48M | -5M | -12.66M | -12.72M | |||||
Other Operating Expenses, Total | 273M | 286M | 292M | 360M | 376M | |||||
Operating Income | 115M | 153M | 150M | 186M | 221M | |||||
Interest Expense, Total | -24.7M | -20.76M | -20.7M | -27.96M | -50.44M | |||||
Interest And Investment Income | 2.65M | 1.46M | 1.33M | 1.98M | 3.8M | |||||
Net Interest Expenses | -22.05M | -19.31M | -19.38M | -25.97M | -46.63M | |||||
Income (Loss) On Equity Invest. | 25K | 27K | - | - | - | |||||
Currency Exchange Gains (Loss) | -27K | -1.3M | -586K | -483K | -1.59M | |||||
Other Non Operating Income (Expenses) | -3.54M | -1.01M | -200K | -2.53M | 671K | |||||
EBT, Excl. Unusual Items | 89.5M | 132M | 130M | 158M | 174M | |||||
Restructuring Charges | -4.2M | -296K | 18K | 338K | 726K | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | -5.01M | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 814K | 9.4M | 6.08M | 187K | -529K | |||||
Asset Writedown | -112M | -1.48M | -172K | - | - | |||||
Insurance Settlements | 6.59M | 14.4M | 6.01M | 1.22M | 2.68M | |||||
Other Unusual Items | 122M | -18.42M | -14.39M | -18.44M | -9.19M | |||||
EBT, Incl. Unusual Items | 98.17M | 135M | 128M | 141M | 167M | |||||
Income Tax Expense | 15.49M | 45.26M | 40.62M | 38.62M | 47.34M | |||||
Earnings From Continuing Operations | 82.68M | 89.88M | 87.24M | 102M | 120M | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 82.68M | 89.88M | 87.24M | 102M | 120M | |||||
Minority Interest | -1.9M | -1.32M | -3.45M | -6.07M | -3.96M | |||||
Net Income - (IS) | 80.78M | 88.56M | 83.79M | 96.12M | 116M | |||||
Net Income to Common Incl Extra Items | 80.78M | 88.56M | 83.79M | 96.12M | 116M | |||||
Net Income to Common Excl. Extra Items | 80.78M | 88.56M | 83.79M | 96.12M | 116M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.57 | 2.82 | 2.67 | 3.06 | 3.48 | |||||
Basic EPS - Continuing Operations | 2.57 | 2.82 | 2.67 | 3.06 | 3.48 | |||||
Basic Weighted Average Shares Outstanding | 31.4M | 31.4M | 31.4M | 31.4M | 33.34M | |||||
Net EPS - Diluted | 2.57 | 2.82 | 2.67 | 3.06 | 3.48 | |||||
Diluted EPS - Continuing Operations | 2.57 | 2.82 | 2.67 | 3.06 | 3.48 | |||||
Diluted Weighted Average Shares Outstanding | 31.4M | 31.4M | 31.4M | 31.4M | 33.34M | |||||
Normalized Basic EPS | 1.72 | 2.58 | 2.48 | 2.94 | 3.14 | |||||
Normalized Diluted EPS | 1.72 | 2.58 | 2.48 | 2.94 | 3.14 | |||||
Dividend Per Share | 1.2 | 1.25 | 1.25 | 1.25 | 1.25 | |||||
Payout Ratio | 48.78 | 44.39 | 46.84 | 40.83 | 37.18 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 266M | 295M | 280M | 340M | 385M | |||||
EBITA | 174M | 190M | 197M | 236M | 271M | |||||
EBIT | 115M | 153M | 150M | 186M | 221M | |||||
EBITDAR | 280M | 298M | 283M | 344M | 389M | |||||
Effective Tax Rate - (Ratio) | 15.78 | 33.49 | 31.77 | 27.43 | 28.28 | |||||
Total Current Taxes | 36.32M | 40.97M | 45.4M | 41.24M | 53.8M | |||||
Total Deferred Taxes | -20.83M | 4.3M | -4.77M | -2.62M | -6.46M | |||||
Normalized Net Income | 54.04M | 80.89M | 78M | 92.37M | 105M | |||||
Interest Capitalized | - | - | - | - | 277K | |||||
Interest on Long-Term Debt | - | 1.18M | 1.49M | 2.06M | 5.04M | |||||
Non-Cash Pension Expense | 1.65M | 1.53M | 1.44M | 1.8M | 4.17M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 6.16M | 9.39M | 12.32M | 23.81M | 18.96M | |||||
Net Rental Expense, Total | 14.41M | 2.95M | 3.42M | 3.34M | 4.18M | |||||
Imputed Operating Lease Interest Expense | 2.86M | 473K | 520K | 635K | 1.5M | |||||
Imputed Operating Lease Depreciation | 11.55M | 2.47M | 2.9M | 2.71M | 2.68M | |||||
Stock-Based Comp., Other (Total) | 1.45M | 3.04M | 886K | 353K | 1.46M | |||||
Total Stock-Based Compensation | 1.45M | 3.04M | 886K | 353K | 1.46M |